Dyadic attends investor events in december

Jupiter, fla., nov. 30, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following investor events during the month of december: noblecon-19 december 3 – 5, 2023florida atlantic university, boca raton, flmark emalfarb, chief executive officerpresentation: tuesday, december 5, 2023, 3:00 pm - 3:25 pm the benchmark company's investor conference thursday, december 7, 2023the new york athletic club 180 central park south, new york, ny if you would like to connect with dyadic's management at any of the events, you may request a one-on-one meeting at hzosiak@dyadic.com.
DYAI Ratings Summary
DYAI Quant Ranking